Treatment of severe community-acquired pneumonia by...

Details Treatment of severe community-acquired pneumonia by... Treatment of severe community-acquired pneumonia by...

A - Human Necessities

61

K

A61K 38/57 (2006.01) A61K 39/395 (2006.01) A61P 11/16 (2006.01)

Patent

CA 2560103

Methods for prophylactically or therapeutically treating severe pneumonia involve administration of tissue factor pathway inhibitor (TFPI) or a TFPI analog to patients suffering from or at risk of developing this condition. The methods involve the use of continuous intravenous infusion of TFPI or a TFPI analog, preferably at low doses to avoid adverse side effects.

Des méthodes pour traiter au plan prophylactique ou thérapeutique une pneumonie grave implique l'administration de l'inhibiteur de parcours de facteur tissu (TFPI) ou un élément analogue au TFPI aux patients souffrant de cette condition ou risquant de la développer. Les méthodes impliquent d'utiliser une infusion intraveineuse continue de TFPI ou d'un élément analogue au TFPI, de préférence à faibles doses pour éviter les effets secondaires.

Affiliated with

Also associated with

Rating

Treatment of severe community-acquired pneumonia by... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of severe community-acquired pneumonia by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of severe community-acquired pneumonia by... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1530885